发明公开
- 专利标题： USE OF [D-MEALA]3-[ETVAL]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MEALA]3-[ETVAL]4-CYCLOSPORIN
- 专利标题（中）： 用[D-MeAla] 3- [ETVAL] 4-环孢素治疗丙型肝炎感染的
-
申请号： EP05791430.1申请日： 2005-10-03
-
公开(公告)号： EP1793844A1公开(公告)日： 2007-06-13
- 发明人: SCALFARO, Pietro , DUMONT, Jean-Maurice , VUAGNIAUX, Grégoire , MAUVERNAY, Rolland-Yves
- 申请人： DEBIOPHARM S.A.
- 申请人地址： Forum "après-demain", Ch. Messidor 5-7 1002 Lausanne CH
- 专利权人： DEBIOPHARM S.A.
- 当前专利权人： DEBIOPHARM S.A.
- 当前专利权人地址： Forum "après-demain", Ch. Messidor 5-7 1002 Lausanne CH
- 代理机构： Grosfillier, Philippe
- 优先权： PCT/IB2004/003205 20041001
- 国际公布： WO2006038088 20060413
- 主分类号： A61K38/13
- IPC分类号： A61K38/13 ; A61P31/14
摘要：
This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.
公开/授权文献
信息查询
IPC分类:
